ArticleHaematologica2017

Progression in patients with low- and intermediate-1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutations.

Christian Scharenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.